Added Value of SPECT/CT in Post Lu-177 Dotatate Treatment for Neuroendocrine Tumors

被引：0
|
作者：
Couch, Paige [1 ]
Webb, Chelsea [2 ]
Botkin, Crystal [1 ]
Frye, Sarah [1 ]
Muzaffar, Razi [2 ]
Osman, Medhat [2 ]
机构：
[1] St Louis Univ, Nucl Med Technol Program, Dept Clin Hlth Sci, Doisy Coll Hlth Sci, St Louis, MO 63103 USA
[2] St Louis Univ, Dept Radiol, Div Nucl Med, St Louis, MO 63103 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2044
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Post Lu-177 PRRT Scintigraphy; Value of SPECT-CT
    Younis, M. Numair
    Khan, I. U.
    Masood, M.
    Shahid, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S579 - S579
  • [2] Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors
    Satapathy, Swayamjeet
    Bhattacharya, Anish
    Sood, Ashwani
    Kapoor, Rakesh
    Gupta, Rajesh
    Sood, Apurva
    Sharma, Prashant
    Khosla, Divya
    Mittal, Bhagwant Rai
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (01) : 23 - 29
  • [3] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [4] Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE (Lutathera®) Case
    Anissa Barakat
    Lore Santoro
    Myrtille Vivien
    Pierre-Olivier Kotzki
    Emmanuel Deshayes
    Sonia Khier
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 329 - 339
  • [5] Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE -(Lutathera®) Case
    Barakat, Anissa
    Santoro, Lore
    Vivien, Myrtille
    Kotzki, Pierre-Olivier
    Deshayes, Emmanuel
    Khier, Sonia
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (04) : 329 - 339
  • [6] Comparison of carrier-added and non-carrier added Lu-177 DOTATATE in patients with Neuroendocrine Tumours
    Roach, P.
    Hain, S.
    Hsiao, E.
    Aslani, A.
    Bailey, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S420 - S420
  • [7] Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
    Josephine Graf
    Ulrich-Frank Pape
    Henning Jann
    Timm Denecke
    Ruza Arsenic
    Winfried Brenner
    Marianne Pavel
    Vikas Prasad
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 881 - 894
  • [8] Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
    Graf, Josephine
    Pape, Ulrich-Frank
    Jann, Henning
    Denecke, Timm
    Arsenic, Ruza
    Brenner, Winfried
    Pavel, Marianne
    Prasad, Vikas
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 881 - 894
  • [9] A shared experience in the treatment of neuroendocrine tumors (NET) with 177 Lu dotatate
    Lobo, G.
    Veras, M.
    Gomes, G.
    Tinoco Mesquita, C.
    Magalhaes, J.
    Hungria, P.
    Ramos, R.
    Barlete, A.
    Santos, T.
    Sadeck, G.
    Ker, W.
    Lavatori, N.
    Cotrado, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S419 - S419
  • [10] Lu-177 DOTATATE dosimetry for neuroendocrine tumor: single center experience
    Said, M. A.
    Masud, M. A.
    Zaini, M. Z.
    Salleh, R. A.
    Lee, B. N.
    Zainon, R.
    10TH INTERNATIONAL SEMINAR ON MEDICAL PHYSICS & 1ST AMDI INTERNATIONAL ONCOLOGY SYMPOSIUM, 2017, 851
12345